All Stories

  1. Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer

    Article • Breast Cancer Research, April 2026, Springer Science + Business Media

    Kosuke Kawaguchi

  2. Genomic and transcriptomic profiling of pre‐ and postneoadjuvant chemotherapy triple negative breast cancer tumors

    Article • Cancer Science, October 2024, Wiley

    Kosuke Kawaguchi

  3. Stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein respons

    Article • January 2024, Springer Science + Business Media

    Kosuke Kawaguchi

  4. Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis

    Article • Breast Cancer Research and Treatment, December 2023, Springer Science + Business Media

    Kosuke Kawaguchi

  5. Cellular senescence triggers intracellular acidification and lysosomal pH alkalinized via ATP6AP2 attenuation in breast cancer cells

    Article • Communications Biology, November 2023, Springer Science + Business Media

    Kosuke Kawaguchi

  6. Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: Propensity score matching and inverse probability of treatment weighting analysis

    Article • June 2023, Springer Science + Business Media

    Kosuke Kawaguchi

  7. Tumor immune microenvironment and systemic response in breast cancer

    Article • Medical Oncology, September 2022, Springer Science + Business Media

    Kosuke Kawaguchi

  8. Serum amyloid alpha 1-2 are not required for systemic inflammation in the 4T1 murine breast cancer model

    Article • September 2022, Cold Spring Harbor Laboratory Press

    Kosuke Kawaguchi

  9. Subcategory classifications of Breast Imaging and Data System (BI-RADS) category 4 lesions on MRI

    Article • Japanese Journal of Radiology, September 2020, Springer Science + Business Media

    Kosuke Kawaguchi

  10. Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy

    Article • Nature Biotechnology, February 2020, Springer Science + Business Media

    Kosuke Kawaguchi

  11. DNA damage repair functions and targeted treatment in breast cancer

    Article • Breast Cancer, January 2020, Springer Science + Business Media

    Kosuke Kawaguchi

  12. Alteration of specific cytokine expression patterns in patients with breast cancer

    Article • Scientific Reports, February 2019, Springer Science + Business Media

    Kosuke Kawaguchi

  13. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients

    Article • Breast Cancer, October 2018, Springer Science + Business Media

    Kosuke Kawaguchi

  14. Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2

    Article • Science Translational Medicine, March 2018, American Association for the Advancement of Science

    Kosuke Kawaguchi

  15. Targeting CXCR4-dependent immunosuppressive Ly6C low monocytes improves antiangiogenic therapy in colorectal cancer

    Article • Proceedings of the National Academy of Sciences, September 2017, Proceedings of the National Academy of Sciences

    Kosuke Kawaguchi

  16. Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity

    Article • Medical Oncology, April 2017, Springer Science + Business Media

    Kosuke Kawaguchi

  17. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer

    Article • December 2016, Springer Science + Business Media

    Kosuke Kawaguchi

  18. Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer

    Article • Breast Cancer, March 2016, Springer Science + Business Media

    Kosuke Kawaguchi

  19. Assessing the effects of neoadjuvant chemotherapy on lymphatic pathways to sentinel lymph nodes in cases of breast cancer: Usefulness of the indocyanine green-fluorescence method

    Article • The Breast, June 2015, Elsevier

    Kosuke Kawaguchi

  20. Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients

    Article • BMC Cancer, February 2015, Springer Science + Business Media

    Kosuke Kawaguchi

  21. Antipsychotics-Containing Regimen As an Alternative to Standard Antiemetics for Delayed Nausea Induced by Highly Emetogenic Chemotherapy

    Article • Journal of Clinical Oncology, April 2013, American Society of Clinical Oncology (ASCO)

    Kosuke Kawaguchi

  22. Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: a multi-institution survey

    Article • Breast Cancer Research and Treatment, June 2011, Springer Science + Business Media

    Kosuke Kawaguchi